These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


278 related items for PubMed ID: 12186116

  • 1. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI.
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [Abstract] [Full Text] [Related]

  • 2. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [Abstract] [Full Text] [Related]

  • 3. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T.
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V, Snehalatha C, Ramachandran A, Viswanathan M.
    J Assoc Physicians India; 1990 Aug 12; 38(8):537-41. PubMed ID: 2123183
    [Abstract] [Full Text] [Related]

  • 6. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG.
    Acta Diabetol; 2009 Mar 12; 46(1):63-5. PubMed ID: 18825302
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetes.
    Forst T, Eriksson JW, Strotmann HJ, Bai S, Brunelle R, Gulliya KS, Gack S, Gudat U.
    Exp Clin Endocrinol Diabetes; 2003 Apr 12; 111(2):97-103. PubMed ID: 12746761
    [Abstract] [Full Text] [Related]

  • 8. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B, Estopá A, Borrás J, Sabaté A.
    Med Clin (Barc); 1998 Nov 07; 111(15):568-72. PubMed ID: 9859089
    [Abstract] [Full Text] [Related]

  • 9. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun 07; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

  • 10. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
    Galic E, Vrtovec M, Bozikov V, Schwarzenhofer M, Milicevic Z.
    Med Sci Monit; 2005 Dec 07; 11(12):PI87-92. PubMed ID: 16319804
    [Abstract] [Full Text] [Related]

  • 11. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M, Bauduceau B, Brun JM, Guillon-Metz F, Martin C, Nicolino-Peltier C, Richard JL, Vannereau D.
    Diabetes Metab; 1998 Feb 07; 24(1):55-61. PubMed ID: 9534010
    [Abstract] [Full Text] [Related]

  • 12. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH, Johns D, Strand J, Halse J, Madsbad S, Eriksson JW, Clausen J, Konkoy CS, Herz M, GLAC Study Group.
    Diabet Med; 2004 Aug 07; 21(8):859-66. PubMed ID: 15270789
    [Abstract] [Full Text] [Related]

  • 13. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T, Møller MK, Chen JW, Laursen T, Jørgensen C, Smedegaard JS, Lauritzen T, Christiansen JS.
    Diabetes Obes Metab; 2008 Jul 07; 10(7):556-63. PubMed ID: 17593233
    [Abstract] [Full Text] [Related]

  • 14. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L, Koenen C, Weng W, Selam JL.
    Diabetes Obes Metab; 2007 Nov 07; 9(6):902-13. PubMed ID: 17924873
    [Abstract] [Full Text] [Related]

  • 15. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y, Oba K, Futami-Suda S, Norose J, Yasuoka H, Suzuki K, Ouchi M, Watanabe K, Suzuki T, Nakano H.
    Geriatr Gerontol Int; 2008 Sep 07; 8(3):160-5. PubMed ID: 18821999
    [Abstract] [Full Text] [Related]

  • 16. Effects of insulin-oral hypoglycemic agents combined therapy in outpatients with type 2 diabetes.
    Sinagra D, Scarpitta AM, Amato M.
    Eur Rev Med Pharmacol Sci; 1998 Sep 07; 2(5-6):175-9. PubMed ID: 10710815
    [Abstract] [Full Text] [Related]

  • 17. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.
    Metabolism; 2008 Nov 07; 57(11):1552-7. PubMed ID: 18940393
    [Abstract] [Full Text] [Related]

  • 18. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
    Langer O, Yogev Y, Xenakis EM, Rosenn B.
    Am J Obstet Gynecol; 2005 Jan 07; 192(1):134-9. PubMed ID: 15672015
    [Abstract] [Full Text] [Related]

  • 19. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.
    Clin Ther; 2004 Sep 07; 26(9):1492-7. PubMed ID: 15531011
    [Abstract] [Full Text] [Related]

  • 20. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A.
    Clin Ther; 2007 Jun 07; 29(6):987-99. PubMed ID: 17692716
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.